Private Wealth Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Private Wealth Management Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.54K	Hold	24	–	–	﹤0.01%	808
2025 Q4	$4.08K	Hold	24	–	–	﹤0.01%	855
2025 Q3	$3.16K	Hold	24	–	–	﹤0.01%	958
2025 Q2	$2.55K	Sell	24 -41	-63%	-$4.45K	﹤0.01%	1005
2025 Q1	$8.07K	Hold	65	–	–	﹤0.01%	544
2024 Q4	$8.01K	Sell	65 -10	-13%	-$1.18K	﹤0.01%	561
2024 Q3	$8.36K	Hold	75	–	–	﹤0.01%	513
2024 Q2	$8.01K	Buy	+75	New	+$8.25K	﹤0.01%	513

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Private Wealth Management Group's JAZZ Position: Q1 2026 in Review

Private Wealth Management Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 24 shares worth $4.54K. The position accounts for ﹤0.01% of the portfolio, ranked #808.

Private Wealth Management Group first reported a position in JAZZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $8.36K in Q3 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Private Wealth Management Group held 24 shares of Jazz Pharmaceuticals worth $4.54K as of Q1 2026.
Private Wealth Management Group left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q1 2026, its #808 holding.
Private Wealth Management Group first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Private Wealth Management Group's Jazz Pharmaceuticals position peaked at $8.36K in Q3 2024.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Private Wealth Management Group's 13F filing for Q1 2026, filed 23 Apr 2026.